New Jersey Commission on Cancer Research (NJCCR)

A doctor consoling her patient.

Fight Cancer Through Research

Cancer is the 2nd leading cause of death in New Jersey. Every donation counts.

Donate today

About NJCCR

The New Jersey Commission on Cancer Research (NJCCR) was established on January 17, 1983, with the passage of the “Cancer Research Act” by the New Jersey State Legislature. NJCCR promotes significant and original research related to Cancer in New Jersey. The NJCCR functions as an independent body and serves as an important resource to providers and consumers of cancer services in the State.

The mission of the NJCCR is to ensure that the citizens of New Jersey receive the fullest benefit of our nation’s fight against cancer through the promotion and funding of research into the causes, prevention, and treatment of cancer.

In pursuit of this mission, NJCCR funds cancer research focused on fostering fundamental creative discoveries, innovation, and improving health disparities in New Jersey.

NJCCR Objectives

NJCCR’s primary objectives include:

  • Review and authorize approved cancer research projects;
  • Apportion all available funds to qualifying research institutions to finance approved research projects and necessary institutional support services;
  • Ensure that funds appropriated to approved research projects are not diverted to any other use;
  • Take steps necessary to encourage the development within the State of research projects on:
    • the causes of cancer;
    • pain management and palliative care for persons diagnosed with cancer and
  • Provide the Governor and the Legislature with an Annual Report describing the state of the commission’s activities and the results of its funded research efforts.

Grant Opportunities

Each year the NJCCR receives a state appropriation to facilitate its mission of advancing cancer research in New Jersey. Additional funding for research grants comes from donations made on New Jersey State Individual Tax forms line #71 and proceeds from the specialty Conquer Cancer license plates.

2026 Grant Opportunities

RFA - NJCCR Request for Applications 2026

TA Session Informartion

Below are the date and time for the Virtual Pre-Award TA session. The meeting link is provided, and no registration is required. Simply join the meeting at the specified date and time using the link below.

  • Date: December 9, 2024
  • Time: 9AM-11AM
  • Location: Microsoft Teams
  • Meeting ID: 226 702 036 164
  • Passcode: Q2tnR7
  • Join by phone: +1 856-338-7074
  • Phone conference ID: 353 738 352#

Questions?

Email NJCCR@doh.nj.gov for more information

 

Public Meeting Calendar

In compliance with the Open Public Meeting Act (NJSA 10:4-6 – 10:4-21) the following meetings are scheduled for the NJCCR:

Date/Time

Location

June 11, 2024 (Closed Executive Session)
9:00 AM - 10:00 AM

Microsoft Teams
Email: njccr@doh.nj.gov to register

October 15, 2024
9:00 AM - 10:00 AM

Microsoft Teams
Email: njccr@doh.nj.gov to register

November 13, 2024 (Annual Symposium & Business Meeting)
9:00 AM - 10:00 AM

Microsoft Teams
Email: njccr@doh.nj.gov to register

 

Donate to Cancer Research

Scientists working in a lab

General Cancer Research Fund

Donating to the general cancer research fund supports cancer research grants administered by NJCCR.

Donate today

A child wearing goggles and a dog wearing goggles in a toy car riding together.

Drive Hope Forward

Donate to support studies focusing on the causes, prevention, screening, treatment, and cure of childhood cancer.

Donate today

An example of a New Jersey Conquer Cancer License Plate

Conquer Cancer License Plates

These plates spread a message of hope and strengthen New Jersey's fight against cancer.

Order a Conquer Cancer License Plate

 

Commission Members, Pediatric Advisory Group, and NJCCR Staff

NJCCR membership consists of 11 members who are volunteers appointed by the Governor.

New Jersey residents wishing to be considered for appointment may submit his/her name to the Governor’s Office of Appointments. Information on how to apply can be found at: https://www.nj.gov/governor/admin/bca.

Commission Members

(Chair)
Kenneth R. Adler
Morristown Medical Center

(Vice-Chair)
Kathleen Scotto
Rutgers School of Biomedical and Health Sciences

Generosa Grana
M.D. Anderson Cancer Center at Cooper

Wendy Budin
Rutgers School of Nursing

Li Li
Novartis Pharmaceuticals Corporation

Shawna Hudson
Rutgers Robert Wood Johnson Medical School

Christine Schell
New Jersey Department of Environmental Protection

Loletha Johnson (Commissioner’s Designee)
New Jersey Department of Health

Michele L. Donato
Hackensack University Medical Center

Jane Flint
Princeton University

 

Pediatric Advisory Group

(Chair)
Aubrey Reichard-Eline

Rutgers Cancer Institute of New Jersey

(Co-Chair)
Peter Cole

Rutgers Cancer Institute of New Jersey

Paulette Forbes

Rutgers Cancer Institute of New Jersey

Daniel Notterman

Robert Wood Johnson University Hospital

Alfred Gillio

Hackensack University Medical Center   

Ahmed-Rafat

Cooper Medical School of Rowan University

 

NJCCR Staff

Lisa H. Cummings
Executive Director

Candido Africa
Program Management Officer

Amir Bhochhibhoya
Program Management Officer

Anita Madavane
Grants Management Officer

 

Contact Information

New Jersey Commission on Cancer Research
PO Box 364, 25 South Stockton Street, 2nd Floor Rear
Trenton, NJ 08625

Email: NJCCR@doh.nj.gov
Phone: 609-913-5015

 

Last Reviewed: 11/25/2024